COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,544 Articles (22,881 medRxiv, 8,663 bioRxiv)

Most recent first Previous |  Page 1054: Articles 10531-10540  | Next

Long-lasting cellular immunity to SARS-CoV-2 following infection or vaccination and implications for booster strategies
Mazzoni, A., Vanni, A., Spinicci, M., Lamacchia, G., Kiros, S. T., Rocca, A., Capone, M., Di Lauria, N., Salvati, L., Carnasciali, A., Mantengoli, E., Farahvachi, P., Zammarchi, L., Lagi, F., Colao, M. G., Liotta, F., Cosmi, L., Maggi, L., Bartoloni, A., Rossolini, G. M., Annunziato, F.
10.1101/2021.12.29.21268469 — Posted: 2021-12-31
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
Roessler, J., Pich, D., Albanese, M., Wratil, P. R., Kraehling, V., Hellmuth, J. C., Scherer, C., Bergwelt-Baildon, M. v., Becker, S., Keppler, O. T., Brisson, A., Zeidler, R., Hammerschmidt, W.
10.1101/2021.12.29.21268487 — Posted: 2021-12-31
Immunomodulation by intravenous omega-3 fatty acid treatment in older subjects hospitalized for COVID-19: a single-blind randomized controlled trial
Arnardottir, H., Pawelzik, S.-C., Sarajlic, P., Quaranta, A., Kolmert, J., Religa, D., Wheelock, C. E., Back, M.
10.1101/2021.12.27.21268264 — Posted: 2021-12-31
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Di Fusco, M., Lin, J., Vaghela, S., Lingohr-Smith, M., Nguyen, J. L., Scassellati Sforzolini, T., Judy, J., Cane, A., Moran, M. M.
10.1101/2021.12.29.21268511 — Posted: 2021-12-31
Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
Bekliz, M., Adea, K., Vetter, P., Eberhardt, C. S., Hosszu-Fellous, K., Vu, D.-L., Puhach, O., Essaidi-Laziosi, M., Waldvogel-Abramowski, S., Stephan, C., L'Huillier, A., Siegrist, C.-A., Didierlaurent, A. M., Kaiser, L. M., Meyer, B., Eckerle, I.
10.1101/2021.12.28.21268491 — Posted: 2021-12-31
A cohort study of the effect of SARS-CoV-2 point of care rapid RT-PCR at the Emergency Department on targeted admission
Mortazavi, S. E., Inghammar, M., Christansen, C., Pesola, A.-K., Stenkilsson, M., Paulsson, M.
10.1101/2021.12.29.21268501 — Posted: 2021-12-31
The Effect of Weather Pattern on the Second Wave of Coronavirus: A cross study between cold and tropical climates of France, Italy, Colombia, and Brazil
Islam, A.
10.1101/2021.12.28.21268496 — Posted: 2021-12-31 Discussion: Onsite
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement
McCallum, M., Czudnochowski, N., Rosen, L. E., Zepeda, S. K., Bowen, J. E., Dillen, J. R., Powell, A., Croll, T., Nix, J., Virgin, H. W., Corti, D., Snell, G., Veesler, D.
10.1101/2021.12.28.474380 — Posted: 2021-12-31
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection
Boucau, J., Chew, K. W., Choudhary, M. C., Deo, R., Regan, J., Flynn, J. P., Crain, C. R., Hughes, M. D., Ritz, J., Moser, C., Dragavon, J. A., Javan, A. C., Nirula, A., Klekotka, P., Greninger, A., Coombs, R. W., Fischer, W. A., Daar, E. S., Wohl, D. A., Enron, J. J., Currier, J. S., Smith, D. M., Li, J. Z., Barczak, A. K., ACTIV-2/A5401 Study Team
10.1101/2021.12.25.21268211 — Posted: 2021-12-30
Detection of the omicron variant in international travellers and their family contacts in India
Potdar, V. A., Yadav, P., lole, K., Cherian, S., Shastri, J., Malhotra, B., Bhardwaj, s. D., Razdan, A., Choudhary, M. L., Gupta, N., Abraham, P.
10.1101/2021.12.27.21268429 — Posted: 2021-12-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).